✦ LIBER ✦

Validation of a Genomic Classifier for Predicting Metastasis Following Postoperative Radiation Therapy in High-Risk Prostate Cancer

✍ Scribed by Den, R.B.; Karnes, R.; Feng, F.Y.; Showalter, T.N.; Mishra, M.V.; Trabulsi, E.J.; Lallas, C.D.; Gomella, L.G.; Birbe, R.; McCue, P.; Yousefi, K.; Ghadessi, M.; Davicioni, E.; Kelly, W.; Knudsen, K.E.; Dicker, A.P.

Book ID: 126886393
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 57 KB
Volume: 90
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2014.05.641

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

205 Validation of a genomic classifier f

205 Validation of a genomic classifier for predicting biochemical failure following post-operative radiation therapy in high-risk prostate cancer

✍ Karnes, R.J.; Den, R.; Feng, F.; Showalter, T.; Mishra, M.; Trabulsi, E.; Lallas 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 201 KB

MP79-01 VALIDATION OF A GENOMIC CLASSIFI

MP79-01 VALIDATION OF A GENOMIC CLASSIFIER FOR PREDICTING CLINICAL PROGRESSION FOLLOWING POST-OPERATIVE RADIATION THERAPY IN HIGH-RISK PROSTATE CANCER

✍ Trabulsi, Edouard; Karnes, Jeffrey; Feng, Felix; Showalter, Timothy; Mishra, Mar 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 41 KB

Validation of a Genomic-Clinical Classif

Validation of a Genomic-Clinical Classifier for Predicting Clinical Progression in Postprostatectomy High-risk Prostate Cancer

✍ Ghadessi, M.; Bergstralh, E.J.; Buerki, C.; Black, P.C.; Erho, N.G.; Crisan, A.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Validation of a Genomic Classifier that

Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population

✍ Karnes, R. Jeffrey; Bergstralh, Eric J.; Davicioni, Elai; Ghadessi, Mercedeh; Bu 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 757 KB

Prostate Cancer in the Era of High-Dose

Prostate Cancer in the Era of High-Dose Radiation Therapy: Presence of Multiple Intermediate-Risk Factors Is Not a Valid Surrogate for High-Risk Disease

✍ Hearn, J.W.; Reddy, C.A.; Weller, M.A.; Kotecha, R.R.; Marwaha, G.; Ciezki, J.P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Initial decline in hemoglobin during neo

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

✍ Anthony V. D'Amico; Tara Saegaert; Ming-Hui Chen; Andrew A. Renshaw; Daniel Geor 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND Declines in serum hemoglobin (Hgb) levels occur from the use of androgen suppression therapy (AST) in the treatment of prostate cancer patients. We studied whether time to prostate specific antigen (PSA) failure following external beam radiation therapy (RT) and AST could